A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
Authors
Keywords
COVID-19, SARS-CoV-2, vaccine, safety, efficacy
Journal
MOLECULAR THERAPY
Volume 29, Issue 9, Pages 2794-2805
Publisher
Elsevier BV
Online
2021-08-06
DOI
10.1016/j.ymthe.2021.08.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- (2021) Anton Pottegård et al. BMJ-British Medical Journal
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Age and frailty in COVID-19 vaccine development
- (2020) Melissa K Andrew et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 vaccines: The status and perspectives in delivery points of view
- (2020) Jee Young Chung et al. ADVANCED DRUG DELIVERY REVIEWS
- Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials
- (2019) Andrew Clark et al. LANCET INFECTIOUS DISEASES
- Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
- (2019) Laura M Nic Lochlainn et al. LANCET INFECTIOUS DISEASES
- Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies
- (2019) Xiao Shi et al. Stem Cell Research & Therapy
- Sex differences in vaccine-induced humoral immunity
- (2018) Stephanie Fischinger et al. Seminars in Immunopathology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started